Estrogen receptor-alpha dependency of estrogen's stimulatory action on cancellous bone formation in male mice.
We examined whether estrogen receptor (ER)alpha is required for estrogen to stimulate cancellous bone formation in long bones of male mice. 17 beta-Estradiol (E(2)) was administered to ER alpha(-/-) male mice or wild-type (WT) littermate controls at 40, 400, or 4000 microg/kg by daily sc injection for 28 d and histomorphometric analysis performed at the distal femoral metaphysis. In WT mice, treatment with E(2) (40 microg/kg per d) increased the proportion of cancellous bone surfaces undergoing mineralization and stimulated mineral apposition rate. In addition, higher doses of E(2) induced the formation of new cancellous bone formation surfaces in WT mice. In contrast, E(2) had little effect on any of these parameters in ER alpha(-/-) mice. Immunohistochemistry was subsequently performed using an ER alpha-specific C-terminal polyclonal antibody. In WT mice, ER alpha was expressed both by cancellous osteoblasts and a significant proportion of mononuclear bone marrow cells. Immunoreactivity was also observed in cancellous osteoblasts of ER alpha(-/-) mice, resulting from expression of the activation function-1-deficient 46-kDa ER alpha isoform previously reported to be expressed in normal osteoblasts and bones of ER alpha(-/-) mice. Taken together, our results suggest that estrogen stimulates bone formation in mouse long bones via a mechanism that requires the presence of full-length ER alpha possessing activation function-1.
McDougall
Kathleen E
KE
Academic Rheumatology, University of Bristol, Bristol BS2 8HW, United Kingdom.
Perry
Mark J
MJ
Gibson
Rachel L
RL
Colley
Shane M
SM
Korach
Kenneth S
KS
Tobias
Jonathan H
JH
D000818:Animals; D004305:Dose-Response Relationship, Drug; D004958:Estradiol / Q000008:administration & dosage / Q000494:pharmacology*; D047628:Estrogen Receptor alpha; D005269:Femur / Q000187:drug effects / Q000254:growth & development / Q000473:pathology / Q000503:physiopathology; D007150:Immunohistochemistry / Q000379:methods; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout / Q000235:genetics; D010006:Osteoblasts / Q000378:metabolism; D010012:Osteogenesis / Q000187:drug effects* / Q000502:physiology; D011960:Receptors, Estrogen / Q000172:deficiency / Q000235:genetics / Q000378:metabolism*; D012016:Reference Values; D013194:Staining and Labeling; D013977:Tibia / Q000378:metabolism / Q000473:pathology
D047628:Estrogen Receptor alpha; D011960:Receptors, Estrogen; D004958:Estradiol